The authors reported that the TCR mimic required tumor cells to induce expression of the immunoproteasome in order to correctly process the PRA300–309 peptide, as demonstrated by the lack of Pr20 binding and ADCC in several HLA-A2+ PRAME+ melanoma cell lines. Here, PRAME is linked to neoplasm.